Cetera Investment Advisers »

Leap Therapeutics shares owned by Cetera Investment Advisers

Quarter-by-quarter ownership of Leap Therapeutics (CYPH) shares owned by Cetera Investment Advisers from 13F filings

Historical chart of Cetera Investment Advisers investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Cetera Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Cetera Investment Advisers

Quarter filed Position value Share count Share price at filing
2025-12-31 $12k 10k 1.16

More positions owned by Cetera Investment Advisers

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds Value Etf (VTV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Growth Etf (VUG)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Schwab Strategic Tr Us Dividend Eq (SCHD)

View all positions for Cetera Investment Advisers

Top funds holding Leap Therapeutics

BlackRock
Vanguard Group
Simplify Asset Management
Susquehanna International
Geode Capital Management
Group One Trading
State Street Corporation
Texas Capital Bank Wealth Management Services
Two Sigma Advisers
Northern Trust
Key Client Fiduciary Advisors
Citadel Advisors
Two Sigma Investments
Simplex Trading
Qube Research & Technologies

View all funds holding Leap Therapeutics